Merck & Company, Inc. (NYSE:MRK) is reporting third quarter earnings results on Tuesday 27th October 2020, before market open.
The consensus estimates from Thomson Reuters are income of $ 1.43 per share.
For the full year, analysts predict revenues of $ 48000.20 million, while looking forward to income of $ 5.71 per share.
The Company Outlook
Full Year 2020 topline are forecasted in a range of$ 47,200.00 million ~ $ 48,700.00 million, where as bottomline are predicted in a range of $ 5.63 ~ $ 5.78 per share
Click Here For More Historical Outlooks Of Merck & Company, Inc.
Previous Quarter Performance
Merck & Company, Inc. announced income for the second quarter of $ 1.37 per share, from the revenue of $ 10,872.00 million. The quarterly earnings expanded 5.38 percent while revenues decreased 7.55 percent compared with the same quarter last year.
Wall street analysts are predicting, MRK to report 2Q20 income of $ 1.04 per share from revenue of $ 10385.80 million. The bottom line results beat street analysts by $ 0.33 or 31.73 percent, at the same time, top line results outshined analysts by $ 486.20 million or 4.68 percent.
Stock Performance
Shares of Merck & Company, Inc. traded up $ 0.62 or 0.78 percent on Friday, reaching $ 79.83 with volume of 6.79 million shares. Merck & Company, Inc. has traded high as $ 80.62 and has cracked $ 79.26 on the downward trend
According to the previous trading day, closing price of $ 79.83, representing a 21.39 % increase from the 52 week low of $ 65.25 and a 14.5 % decrease over the 52 week high of $ 92.64.
The company has a market capital of $ 201.91 billion and is part of the Healthcare sector and Drug Manufacturers – Major industry.
Recent Analyst recommendations
- On 16th October 2020, maintained by JPMorgan Chase & Co. at Overweight rating, with $ 105.00 target price.
- On 29th September 2020, initiated by Berenberg Bank at Hold rating, with $ 88.00 target price.
Recent Stock Dividend Announcement
The board of directors has authorized quarterly dividend of $ 0.61 per share on July 28, 2020. The dividend were payable on October 7, 2020 to holders of record as of the close of business on September 15, 2020 and ex-dividend date on September 14, 2020.
Conference Call
Merck & Company, Inc. will be hosting a conference call at 8:00 AM eastern time on 27th October 2020, to discuss its 3Q20 financial results with the investment community. A live webcast with presentations will be available on the Internet by visiting the Company website www.merck.com
Merck & Co., Inc. provides healthcare solutions worldwide. It operates through four segments: Pharmaceutical, Animal Health, Healthcare Services, and Alliances.
